Total planned funding: $457,370,825
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $117,311,547 |
Mozambique | $93,648,785 |
Kenya | $48,692,030 |
South Africa | $19,703,484 |
Burundi | $18,952,597 |
Zambia | $18,573,528 |
Vietnam | $14,705,582 |
Botswana | $13,299,117 |
Indonesia | $10,520,549 |
Papua New Guinea | $10,393,036 |
Côte d'Ivoire | $10,223,797 |
Democratic Republic of the Congo | $9,930,245 |
Tanzania | $8,854,729 |
India | $8,133,871 |
Asia Regional Program | $7,382,475 |
Uganda | $6,594,603 |
Zimbabwe | $5,558,697 |
Angola | $5,557,878 |
Caribbean Region | $5,236,771 |
Malawi | $4,733,759 |
Central America Region | $3,929,600 |
South Sudan | $3,325,978 |
Dominican Republic | $2,118,747 |
Ethiopia | $2,106,203 |
Eswatini | $1,908,639 |
Haiti | $1,850,756 |
Rwanda | $1,713,822 |
Cameroon | $1,060,000 |
Central Asia Region | $650,000 |
Namibia | $450,000 |
Lesotho | $250,000 |
Ghana | $0 |
Organizational Types
NGO | $457,370,825 |
Program Areas
Care | $146,566,660 |
Treatment | $136,050,734 |
Prevention | $95,572,479 |
Testing | $44,152,703 |
Governance and Systems | $35,028,249 |
Budget Codes
HTXS: Treatment: Adult Treatment | $128,760,496 |
HBHC: Care: Adult Care and Support | $68,475,365 |
HKID: Care: Orphans and Vulnerable Children | $56,502,122 |
HVCT: Testing: HIV Testing and Counseling | $44,152,703 |
HVOP: Sexual Prevention: Other Sexual Prevention | $42,366,478 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $39,416,075 |
OHSS: Health Systems Strengthening | $12,994,285 |
HVSI: Strategic Information | $12,808,509 |
HVTB: Care: TB/HIV | $12,255,872 |
PDCS: Care: Pediatric Care and Support | $9,333,301 |
HLAB: Laboratory Infrastructure | $9,225,455 |
PDTX: Treatment: Pediatric Treatment | $7,290,238 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $6,430,550 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,089,892 |
HMIN: Biomedical Prevention: Injection Safety | $632,051 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $386,853 |
HMBL: Biomedical Prevention: Blood Safety | $250,580 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$457,370,825
View countries